Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Beckers, Johannes  (2)
  • Schaefer, Sabine  (2)
Type of Medium
Person/Organisation
Language
Years
Subjects(RVK)
  • 1
    In: Blood, American Society of Hematology, Vol. 114, No. 22 ( 2009-11-20), p. 3936-3936
    Abstract: Abstract 3936 Poster Board III-872 Introduction The hallmark of MCL is overexpression of cyclin D1 due to the t(11;14). As cyclin D1 plays a central role in cell cycle regulation and influences the activity of several transcription factors, its overexpression is believed to initiate MCL lymphomagenesis. To dissect the transcriptional network regulated by cyclin D1, and to assess the relationship of cyclin D1 to genes comprising the recently described MCL proliferation signature, the consequences of cyclin D1 knockdown were analyzed by comparative gene expression profiling. Materials and Methods Four MCL cell lines, Granta 519, Jeko-1, Rec-1 and Z-138 were transduced with lentivirus containing the cyclin D1 shRNA or with empty lentivirus in triplicates. At day seven after infection, RNA was extracted and used for Gene Chip expression analysis (U133 Plus 2.0 arrays/ Affymetrix). After robust multi-array average (RMA) preprocessing, genes which were differentially expressed in all four cell lines were identified using BioConductor software. Validation was performed by correlating cyclin D1 levels with candidate gene expression by qRT-PCR in 10 primary MCL cases. Results To identify genes regulated by cyclin D1 in all four cell lines, statistical analysis applying a false discovery rate of 10% was performed, thereby accepting only genes with a 〉 1,1 and 〈 0,9 fold ratio and an average expression 〉 25. We identified 344 genes regulated after cyclin D1 knockdown (93 upregulated, 251 downregulated). Classification of the differentially expressed genes to biological processes revealed overrepresentation of genes involved in replication (23,0%), chromatin packaging and remodelling (12,5%), signal transduction (10,5%), metabolism (9,9%), transcription (9,6%) and cell cycle (6,4%). Of the 20 genes comprising the MCL proliferation signature (Rosenwald et al., Blood 2003), 10 were identified as cyclin D1 dependent. These genes were validated in MCL with high vs. low levels of cyclin D1 mRNA. Although there was a direct correlation between these 10 genes and cyclin D1 levels, it is notable that there was no correlation between the proliferation rate as assessed with MiB1 and the level of cyclin D1 expression Conclusions Comparative gene expression profiling before and after knockdown of cyclin D1 in MCL cell lines reveals a complex transcriptional network influenced by cyclin D1 expression levels. We also show that 10 of the 20 genes comprising the MCL proliferation signature are cyclin D1-dependent. These genes showed good correlation with cyclin D1 mRNA levels in primary cases, however, no correlation with proliferation rate was identified, suggesting cyclin D1-independent mechanisms governing proliferation in MCL. The identification of cyclin D1-dependent genes assists in our understanding of the contribution of cyclin D1 overexpression to the biology and clinical course of MCL. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2009
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Blood, American Society of Hematology, Vol. 114, No. 22 ( 2009-11-20), p. 1943-1943
    Abstract: Abstract 1943 Poster Board I-966 Introduction: ALK+ anaplastic large cell lymphomas (ALCL) overexpress C/EBPβ, as a consequence of NPM-ALK kinase activity. We recently reported C/EBPβ as a transcription regulator of NPM-ALK induced cellular proliferation. To identify the downstream targets of C/EBPβ that might be responsible for cell proliferation and survival, we performed gene expression profiling and pathway analyses after C/EBPβ gene silencing Materials and Methods: C/EBPβ knockdown was done by lentiviral shRNA-transduction into two ALK+ ALCL cell lines with strong C/EBPβ expression – SUDHL1 and KiJK. At day three after infection, RNA was extracted and used for Gene Chip expression analysis (U133 Plus 2.0 arrays/ Affymetrix). Genes regulated in both cell lines were applied to Genomatix Bibliosphere Pathway analysis. Candidate genes were either strongly influenced by C/EBPβ knockdown, or had promoter binding sites for C/EBPβ, or showed remarkable pathway connections. The influence of C/EBPβ on these genes was validated by qRT-PCR and in part by Western blot. Results: Gene expression profiling analysis resulted in 167 genes being regulated in both cell lines, of which 26 genes were chosen for further analysis. Validation by qRT-PCR confirmed 23/26 genes. Pathway analysis revealed c-Jun, which is a member of the dimeric transcription factor AP-1, as a regulator of C/EBPβ expression. Silencing C/EBPβ led to a clear up-regulation of c-Jun mRNA. Western blot analysis demonstrated that C/EBPβ influenced not only the expression of c-Jun but also its phosphorylation on Ser63 and Ser73. In contrast to what has been reported, we found very low levels of c-Jun expression in ALK+ALCL cells lines and its expression correlated inversely with C/EBPβ mRNA levels. Although it has been shown that c-Jun regulates C/EBPβ expression directly, in ALK+ALCL the expression of C/EBPβ is clearly independent of c-Jun. Our data suggest that c-Jun up-regulation after C/EBPβ knockdown is a compensatory mechanism to maintain C/EBPβ expression. Additionally, of the 26 selected genes, Bibliosphere Analysis identified 12 genes, which might be transcriptionally regulated by C/EBPβ and are primary targets in C/EBPβ downstream signalling. Two of these genes are of particular interest. The anti-apoptotic protein BCL2A1 contains a promoter-binding site for C/EBPβ and has been shown previously to be both strongly regulated in ALK+ALCL and absolutely necessary for its transformation. The second is a DEAD box nucleolar RNA helicase protein involved in ribosomal RNA production and proliferation which we found to be strongly expressed in ALK+ALCL cell lines and primary cases. Conclusions: C/EBPβ silencing in ALK+ALCL cell lines showed 1) an inverse correlation between c-Jun and C/EBPβ mRNA expression levels, 2) the expression of C/EBPβ in ALK+ALCL is independent of c-Jun, 3) genes transcriptionally regulated by C/EBPβ seem to be essential for proliferation and survival in ALK+ALCL. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2009
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages